<DOC>
	<DOC>NCT00916695</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of the treatment of true bifurcation lesions with the XIENCE V stent using the simple strategy (stent in main vessel and provisional T-stenting in the side branch) compared to the complex strategy (stent in main vessel and T-stenting in the side branch).</brief_summary>
	<brief_title>Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Patients over 18 years old. True Bifurcation lesion (Medina classification 111), in at least one main coronary vessel. Diameter of main vessel between 2,54mm, and diameter of side branch 2mm or greater. Significant left main stenosis. ST elevation myocardial infarction &lt; 48 h. Thrombus burden target lesion. Ejection Fraction &lt; 30%. Severe Renal Insufficiency (creatinine &gt; 3 mg/dl).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Stents</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Bifurcation Coronary Lesions</keyword>
</DOC>